Synthomer Yönetim
Yönetim kriter kontrolleri 1/4
Synthomer CEO'su Michael Willome, Nov2021 tarihinde atandı, in görev süresi 4.5 yıldır. in toplam yıllık tazminatı £ 1.55M olup, şirket hissesi ve opsiyonları dahil olmak üzere 45.2% maaş ve 54.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.18% ine doğrudan sahiptir ve bu hisseler £ 285.52K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 2.7 yıldır.
Anahtar bilgiler
Michael Willome
İcra Kurulu Başkanı
UK£1.6m
Toplam tazminat
| CEO maaş yüzdesi | 45.23% |
| CEO görev süresi | 4.5yrs |
| CEO sahipliği | 0.2% |
| Yönetim ortalama görev süresi | 3.8yrs |
| Yönetim Kurulu ortalama görev süresi | 2.7yrs |
Son yönetim güncellemeleri
Recent updates
SYNT: Cost Actions And Bio-Based Shift Will Support Future Margin Stability
Analysts have slightly reduced their price expectations for Synthomer, reflecting updated assumptions for a less pronounced revenue decline, a small reduction in forecast profit margins, and a modest adjustment to future P/E. Taken together, these changes leave their fair value estimate unchanged at £0.59 per share.
SYNT: Cost Cuts And Bio Based Shift Will Support Future Upside
Analysts have nudged their price target on Synthomer slightly, reflecting modest tweaks to assumptions around discount rate, profit margin and future P/E, while keeping the underlying fair value estimate broadly unchanged at £1.27. What's in the News Godavari Biorefineries Limited entered a partnership with Synthomer to develop bio-based alternatives to existing fossil-based monomers, targeting growing customer demand for lower carbon and more sustainable materials (Key Developments).SYNT: Cost Actions And Bio-Based Partnership Will Support Future Margin Resilience
Analysts have adjusted their Synthomer price targets slightly to reflect updated views on revenue contraction, slightly higher profit margins, and a modestly lower future P/E, resulting in a revised fair value estimate of £0.59 per share. What's in the News Synthomer entered a partnership with Godavari Biorefineries Limited to develop bio-based alternatives to existing fossil-based monomers.SYNT: Cost Actions And Bio Based Shift Will Support Earnings Recovery
Analysts have trimmed their price target on Synthomer from £1.34 to about £1.27, citing updated assumptions on revenue growth, profit margins and future P/E multiples as they reassess the balance of risk and reward. What's in the News Godavari Biorefineries Limited partnered with Synthomer to develop bio-based alternatives to existing fossil-based monomers, including commercialisation of bio-based butyl acrylate using bio-based butanol from GBL, aimed at supporting customer demand for lower carbon materials (Key Developments).SYNT: Cost Actions And Bio-Based Shift Will Support Future Margin Resilience
Analysts have nudged their price target on Synthomer higher to £0.59. This reflects updated assumptions around slightly less severe revenue contraction and broadly unchanged profit margins and P/E expectations.SYNT: Cost Actions And Margin Resilience Will Support A Stable Fair Value View
Analysts have nudged their fair value estimate for Synthomer to £0.59 from £0.55, citing revised assumptions around revenue growth, profit margins and future P/E as the key drivers of the updated price target. What's in the News Synthomer issued earnings guidance for the twelve months to 31 December 2025, with expected 2025 revenue of around £1.74b compared with £1.93b for 2024, described as in line with market expectations (Key Developments).SYNT: Earnings Prospects Will Stabilise As Fair Value View Remains Intact
Analysts have adjusted their price targets on Synthomer, reflecting revised assumptions around revenue growth, profit margins and future P/E multiples. Together, these changes point to a recalibrated view of the company’s earnings potential within an unchanged fair value estimate of £0.55 per share.SYNT: Self Help And 2026 Outlook Will Support Earnings Recovery
Analysts have trimmed their price expectations for Synthomer, with a lower fair value estimate and a reduced Street target to £1.02 from £1.12. This reflects updated views on revenue growth and earnings multiples while maintaining a broadly neutral stance on the shares.SYNT Will Face Mounting Pressure As Earnings Recovery Outlook Deteriorates
The analyst price target for Synthomer has been reduced to £1.02 per share from £1.12, as analysts factor in slower revenue growth assumptions, despite slightly higher profit margin expectations and a marginally increased discount rate. Analyst Commentary Recent research updates highlight a cautious stance from bearish analysts, who have progressively lowered their price targets on Synthomer as they reassess the company’s growth trajectory and risk profile.SYNT: Self-Help Actions Will Drive Earnings Recovery Despite Neutral Market Sentiment
Analysts have trimmed their price target on Synthomer slightly. This reflects a modest recalibration in fair value to approximately £1.34 per share following a series of recent target cuts that have reset expectations for the stock.SYNT: Full-Year Self-Help Actions Will Drive Earnings Recovery Momentum
Analysts have revised their price target for Synthomer downward from GBp 112 to GBp 102. This change is attributed to adjustments to future valuation metrics and an updated earnings outlook.SYNT: Future Gains Are Expected As End Markets Gradually Stabilize
Synthomer's analyst price target has been reduced from 112 GBp to 102 GBp. Analysts cite persistent end-market challenges and limited near-term prospects for earnings recovery as key factors behind the downward revision. Analyst Commentary Recent analyst coverage reflects a spectrum of perspectives regarding Synthomer's outlook, shaped by evolving market dynamics and the company's updated financial guidance.Future Earnings And Recovery Prospects Will Remain Under Pressure Amid Market Challenges
Synthomer's fair value estimate has been revised downward from £1.54 to £1.38 per share. Analysts cite ongoing challenges in end markets and modest growth prospects following the company's recent interim results.UK£1.57: That's What Analysts Think Synthomer plc (LON:SYNT) Is Worth After Its Latest Results
Aug 09
Sustainable Specialty Polymers Will Unlock New Global Opportunities
Despite a notable upgrade in revenue growth forecasts and a reduction in the forward P/E, Synthomer's consensus analyst price target has been revised down from £1.71 to £1.57. Valuation Changes Summary of Valuation Changes for Synthomer The Consensus Analyst Price Target has fallen from £1.71 to £1.57.
Chemical Realignment And Adhesives Expansion Will Build A Resilient Future
Shift to high-margin specialty chemicals and divestment of non-core operations are expected to enhance profitability.Investors Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues
Jan 08Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch
Oct 05Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)
Aug 03Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?
Jun 18Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump
May 25Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 20Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely
Mar 14Should You Think About Buying Synthomer plc (LON:SYNT) Now?
Feb 08Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?
Oct 17Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load
Sep 12CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | -UK£150m |
| Sep 30 2025 | n/a | n/a | -UK£113m |
| Jun 30 2025 | n/a | n/a | -UK£76m |
| Mar 31 2025 | n/a | n/a | -UK£73m |
| Dec 31 2024 | UK£2m | UK£702k | -UK£70m |
| Sep 30 2024 | n/a | n/a | -UK£78m |
| Jun 30 2024 | n/a | n/a | -UK£86m |
| Mar 31 2024 | n/a | n/a | -UK£96m |
| Dec 31 2023 | UK£1m | UK£675k | -UK£105m |
| Sep 30 2023 | n/a | n/a | -UK£127m |
| Jun 30 2023 | n/a | n/a | -UK£149m |
| Mar 31 2023 | n/a | n/a | -UK£84m |
| Dec 31 2022 | UK£987k | UK£650k | -UK£18m |
| Jun 30 2022 | n/a | n/a | UK£80m |
| Mar 31 2022 | n/a | n/a | UK£139m |
| Dec 31 2021 | UK£789k | UK£108k | UK£198m |
Tazminat ve Piyasa: Michael 'nin toplam tazminatı ($USD 2.11M ), UK pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 836.22K ).
Tazminat ve Kazançlar: Michael şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Michael Willome (59 yo)
Mr. Michael Willome, lic. oec. HSG serves as the Chief Executive Officer at Synthomer plc since November 1, 2021 and serves as its Executive Director since November 2021.He had been Group Chief Executive...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Executive Director | 4.5yrs | UK£1.55m | 0.18% £ 285.5k | |
| CFO & Director | 3.8yrs | UK£1.14m | 0.076% £ 120.0k | |
| Vice President of Investor Relations | 3.3yrs | Veri yok | Veri yok | |
| Interim Chief Human Resources Officer | 3.4yrs | Veri yok | Veri yok | |
| President of Health | 7.7yrs | Veri yok | Veri yok | |
| President of Coatings & Construction Solutions and EMEA | 4.3yrs | Veri yok | Veri yok | |
| President of Strategy and M&A | 3.7yrs | Veri yok | Veri yok | |
| President of Adhesive Solutions | 3yrs | Veri yok | Veri yok |
Deneyimli Yönetim: SYNT 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Executive Director | 4.5yrs | UK£1.55m | 0.18% £ 285.5k | |
| CFO & Director | 3.8yrs | UK£1.14m | 0.076% £ 120.0k | |
| Non-Executive Director | 23.7yrs | UK£46.60k | 0.10% £ 158.7k | |
| Independent Non-Executive Director | less than a year | Veri yok | 0.036% £ 57.4k | |
| Independent Non-Executive Chairman | 1.7yrs | UK£20.53k | 0.031% £ 48.5k | |
| Independent Non-Executive Director | 2.7yrs | UK£61.60k | Veri yok | |
| Independent Non-Executive Director | 7.7yrs | UK£71.60k | 0.015% £ 23.3k | |
| Non-Executive Director | 1.7yrs | UK£15.53k | 0.015% £ 24.2k | |
| Senior Independent Director | less than a year | Veri yok | 0.012% £ 19.3k |
Deneyimli Yönetim Kurulu: SYNT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.7 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/02 02:15 |
| Gün Sonu Hisse Fiyatı | 2026/05/01 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Synthomer plc 21 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Katie Richards | Barclays |
| Robert Bate | Barclays |
| James Stewart | Barclays |